Long-Term Outcomes of Two Different Initial Dosing Regimens of Intravitreal Ranibizumab Used to Treat Myopic Choroidal Neovascularization

1. Calvo-González, C.
2. Reche-Frutos, J.
3. Fernández-Vigo, J.I.
4. Sáenz-Francés, F.
5. Fernández-Pérez, C.
6. García-Feijóo, J.